| Identification | Back Directory | [Name]
Dasatinib Impurity 35 | [CAS]
1025814-13-4 | [Synonyms]
Dasatinib Impurity 35
Dasatinib Impurity 83
Dashatinib impurity 35
N-(2-Chloro-6-methylphenyl)-2-((6-((2-((2-hydroxyethyl)amino)ethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide | [Molecular Formula]
C20H24ClN7O2S | [MOL File]
1025814-13-4.mol | [Molecular Weight]
461.97 |
| Hazard Information | Back Directory | [Uses]
N-(2-Chloro-6-methylphenyl)-2-[[6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-2-methyl-4-pyrimidinyl]amino]- 5-thiazolecarboxamide is an impurity in the preparation of Dasatinib (D193600), a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. It is a COVID19-related research product. |
|
|